Pfizer forecasts lower earnings

Note: This section contains information in English only.
Source: Dukascopy Bank SA


On Wednesday, Pfizer announced that their 2024 sales were expected to be $5 billion below Wall Street market expectations.

The announcement caused a major decline of the company's stock price. The stock price of the company lost $2.45 or 8.59% of its value at the start of Wednesday's US trading.

In addition, the company's stock price has declined more than 45% during this year, as an erosion of $10 billion in market capitalization has occurred. The main cause of the decline has been the end of Covid-19 pandemic. Markets had pumped up the stock during the pandemic, as the company had made $100 billion from vaccine sales in 2022. However, there are little to no buyers in 2023.

Actual Topics

Subscribe to "Fundamental Analysis" feed

Subscribe
Pre viac informácií o Dukascopy Bank CFD / Forex obchodných platformách a ostatných záležitostiach
nás prosím kontaktujte alebo požiadajte o hovor od nás.
For further information regarding potential cooperation,
please call us or make callback request.
To learn more about Dukascopy Bank Binary Options / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
Pre viac informácií o Dukascopy Bank CFD / Forex obchodných platformách a ostatných záležitostiach
nás prosím kontaktujte alebo požiadajte o hovor od nás.
To learn more about Crypto Trading / CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Business Introducer and other trading related information,
please call us or make callback request.
For further information regarding potential cooperation,
please call us or make callback request.